Albumin Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Albumin clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting

Family Investigation of Nephropathy and Diabetes (F.I.N.D.)

Diabetes MellitusAlbuminuriaDiabetic Kidney Disease+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)100,000 enrolled1 locationNCT00342927
Recruiting

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Chronic Kidney DiseasesMolecular Sequence VariationAlbuminuria+4 more
Herlev Hospital300 enrolled13 locationsNCT04916132
Recruiting

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

Autonomic DysfunctionHypertensionBlood Pressure Disorders+15 more
Wake Forest University Health Sciences125 enrolled1 locationNCT04752293
Recruiting
Phase 4

ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases

Chronic Kidney DiseaseDiabetic NephropathiesChronic Kidney Disease (Stages 4 and 5)+5 more
Ace Cells Lab Limited300 enrolled1 locationNCT07187713
Recruiting
Not Applicable

Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome

Diabetes MellitusStrokeChronic Kidney Disease(CKD)+4 more
Universidade do Porto150 enrolled1 locationNCT07173062
Recruiting
Phase 2

Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery

Gastric CancerPostoperative ComplicationsPostoperative Hypoalbuminemia
The First Hospital of Jilin University112 enrolled1 locationNCT07119463
Recruiting
Not Applicable

A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel

Breast CancerReal Time Pressure ControllerAlbumin Paclitaxel+1 more
Tianjin Medical University Cancer Institute and Hospital118 enrolled1 locationNCT07019233
Recruiting
Phase 4

Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes

Albuminuria
University of Colorado, Denver50 enrolled1 locationNCT05498116
Recruiting

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

ObesityCardiovascular DiseasesChronic Kidney Diseases+8 more
Swiss Tropical & Public Health Institute1,200 enrolled1 locationNCT05881447
Recruiting

Is the CRP-Albumin-Lymphocyte (CALLY) Index Effective in Predicting Postoperative Delirium in Geriatric Patients Undergoing Hip Fracture Surgery

Postoperative Delirium (POD)Hip FractureCRP+2 more
Ankara Ataturk Sanatorium Training and Research Hospital100 enrolled1 locationNCT06818409
Recruiting
Phase 1Phase 2

Chemoradiotherapy in Unresectable Esophageal Cancer

Esophageal CancerChemoradiotherapyAlbumin-bound Paxlitaxel+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences105 enrolled5 locationsNCT04278287
Recruiting

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

Heart FailureMalignant NeoplasmCirrhosis+5 more
Chinese University of Hong Kong120 enrolled1 locationNCT05797649
Recruiting
Phase 3

PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS

Heart Failure; With DecompensationDiuretics Drug ReactionsAlbumin; Double
Democritus University of Thrace250 enrolled1 locationNCT06630923
Recruiting
Not Applicable

Functionality of Albumin in the Context of Hemodialysis

DialysisUremic; ToxemiaAlbumin+1 more
Universität Duisburg-Essen50 enrolled1 locationNCT06561191
Recruiting
Phase 3

Long term impact of RAS inhibition on cardio-renal outcomes: a comparative trial of angiotensin converting enzyme inhibitors, angiotensin receptor blockers or combined therapy with both agents in patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.

Patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.
Consorzio Mario Negri Sud2,100 enrolled1 locationACTRN12607000333415